Matthijs Moerland (1980) studied Biomedical Sciences at Leiden University. He was trained in vascular biology at the department of Cell Biology of Erasmus University Rotterdam (2002-2006, Prof F.G. Grosveld), where he obtained his PhD investigating lipoprotein metabolism and atherogenesis in humanized animal models. In 2007 he joined CHDR as senior clinical scientist in the Vascular Medicine research group, focusing on the integration of immunology, endocrinology and endovascular reactivity in translational medicine. From 2014 onwards, Matthijs Moerland is heading a separate research area, entitled Translational Biomarkers, which comprises the selection, qualification and implementation of non-routine biomarkers in drug development.
Matthijs MoerlandResearch Director Translational Biomarkers
|T:||+31 (0)71 524 64 54|